Editorial standards

Who writes this and how it is checked. This site is produced by an editorial team using a fixed, documented method: claims are drafted only after the underlying source (an FDA label, a Drugs@FDA record, a peer-reviewed trial report, or a trial registry entry) has been retrieved and read, and each numeric or medical claim about tirzepatide is stored in a public claims ledger with its source URL and an evidence grade. We do not list physician reviewers, because no external clinician has reviewed this content, and we will not invent one. If clinical review is added in the future, the reviewer's real name and role will appear here.

What counts as a source. Primary sources only: FDA prescribing labels (via openFDA), Drugs@FDA approval records, peer-reviewed journal reports indexed on PubMed, ClinicalTrials.gov registry records, and FDA announcements. Blogs, press coverage, and other secondary websites are never citations for tirzepatide facts. Every numeric claim in new copy carries an inline citation, and the full machine-readable ledger (claims-ledger.json) is published so anyone can audit any number. Evidence grades distinguish human randomized trials, FDA label statements, animal findings, and regulatory records; an animal finding is always labeled as animal data.

When this content changes. Pages are dated. We review the tirzepatide content when the FDA label changes, when a pivotal trial publishes, or on a scheduled sweep, whichever comes first. This pack was built against the Zepbound label effective April 22, 2026 and the Mounjaro label effective July 29, 2026; those effective dates are tracked so a label revision triggers a review. Trial-registry facts (such as ongoing outcome trials) carry their access date.

Corrections. If we got a number, a dose, or a safety fact wrong, we want to know. Use the corrections link in the site footer to reach the editorial inbox; verified errors are fixed in the text, noted on this page with the date and what changed, and propagated to the claims ledger. The correction log on this page is permanent.

'cited sources' is the count of unique source URLs in this site's published claims ledger (claims-ledger.json). 'Trial participants' is the sum of the enrollment column of the monograph study table, counting each trial once (the 176-week SURMOUNT-1 extension is a subset of SURMOUNT-1 and is excluded from the sum). Both values are recomputed at build time; if they cannot be recomputed, they do not ship.

We do not publish testimonials or reviews, display trust badges we have not earned, invent reviewer names, or show member counts we cannot measure. The editorial evidence and citations are not supplied by a product vendor. The site does present a commercial care option, clearly separated from educational claims; a completed order may generate revenue for the site owner. This site is educational only and is not medical advice.